Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis
Description
CONCLUSIONS: Molnupiravir does not decrease mortality and hospitalization rates in immunized patients with COVID-19. However, it does shorten the disease course and increases the recovery rate. The use of molnupiravir will need to be considered on a
